Market Overview:
The global electrical ablators market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cancer, technological advancements in ablative devices, and rising demand for minimally invasive surgeries. Based on type, the global electrical ablators market is segmented into argon plasma/beam coagulators and irreversible electroporation ablators. The argon plasma/beam coagulators segment is expected to account for the majority share of the global electrical ablator market in 2018 owing to its high adoption rate across various applications such as cancer treatment, gynecologic treatment, ophthalmologic treatment, and cardiovascular disease treatment. However, the irreversible electroporation ablators segment is projected to grow at a higher CAGR during the forecast period from 2018 to 2030 due to its growing demand for use in non-invasive surgeries. Based on application, the global electrical ablator market is divided into cancer treatment, gynecologic treatment, ophthalmologic treatment Cardiovascular disease (CVD) Treatment,, and other applications.
Product Definition:
Electrical ablators are devices that use electricity to remove material from a surface. They are often used in surgery to remove tumors or cancerous cells. Electrical ablators can also be used to clean metal surfaces or prepare them for welding.
Argon Plasma/Beam Coagulators:
Argon plasma/beam coagulators are devices that interact with the electrical conductors to remove their oxides and create a vacuum which is filled with Ar, Ne or K. These gasses when introduced into the molten metal produce an environment where oxidation can occur more rapidly than in a normal atmosphere. The end result is a much cleaner solidified product and one that has had virtually no contact with air during its production process.
Irreversible Electroporation Ablators:
Irreversible electroporation ablators are used in electrical ablators market. It is a type of energy source that can be used to destroy tissue and cells by causing them to die or stop functioning. The main function of these devices is to remove the outer skin without damaging underlying tissues or organs.
Application Insights:
The other application segment includes the treatment of burns, chronic wounds, and tissue repair. The growing need for tissue repair procedures to treat chronic diseases is expected to drive the demand for electrical ablators over the forecast period. In addition, increasing cases of burn injuries across all age groups in developed as well as developing countries are anticipated to propel market growth over the forecast period.
Electrical ablation has emerged as an effective and safe method for treating various skin conditions including acne scars, warts (benign & malignant), stretch marks (pre-, post-natal), chickenpox pustules/ lesions/sores (acute & chronic) and others. Moreover, it has been proven that this technology is safe even when applied on open wounds or ulcersated ones under medical supervision; this factor is expected to have a positive impact on market growth during future years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of players, high adoption rate for advanced technologies, and favorable reimbursement policies. The region is expected to maintain its dominance over the forecast period due to factors such as increasing geriatric population base with respect cancer rates and cardiovascular diseases. Moreover, rising government initiatives pertaining to R&D investments are also anticipated favorably impact regional growth.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to factors such as economic development coupled with growing medical tourism industry in emerging countries like China & India & Thailand etc., which will boost demand for electrical ablators used for surgeries performed on patients seeking treatment at home country or abroad. In addition, rapidly improving healthcare infrastructure along with supportive government policies are further likely fuel growth over this region’s lifespan.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for electrical ablators is expected to grow at a CAGR of 7.5% during the forecast period. This can be attributed to the increasing demand for minimally invasive surgeries, which offer several benefits over traditional surgical procedures, including shorter hospital stays, reduced pain and blood loss, and faster recovery times.
- Growing prevalence of cancer: The incidence of cancer is on the rise globally due to factors such as aging population, unhealthy lifestyle habits, and environmental pollution. This is expected to drive the demand for electrical ablators as they are widely used in cancer treatment procedures such as tumor ablation and radiofrequency ablation (RFA).
- Technological advancements: The development of new technologies has led to the introduction of advanced electrical ablators that offer better performance and safety than earlier models. This is likely to boost the growth prospects of this market in coming years.
- Rising healthcare expenditure: In developed countries such as the US and Japan, there has been a significant increase in healthcare expenditure in recent years due to rising awareness about health issues among consumers and government initiatives aimed at improving healthcare infrastructure nationwide .This is likely to create opportunities for growth in the global market for electrical ablators over next few years . 5)Growing number of elderly population: With advances in medical technology and improved standards of living, people are living longer than ever before .The growing elderly population is thus creating a large
Scope Of The Report
Report Attributes
Report Details
Report Title
Electrical Ablators Market Research Report
By Type
Argon Plasma/Beam Coagulators, Irreversible Electroporation Ablators
By Application
Cancer Treatment, Gynecologic Treatment, Ophthalmologic Treatment, Cardiovascular Disease Treatment, Other
By Companies
Medtronic, Biosense, St. Jude, Boston, Angiodynamics, Atricure, Smith & Nephew, Galil Medical, Conmed, Olympus
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Electrical Ablators Market Report Segments:
The global Electrical Ablators market is segmented on the basis of:
Types
Argon Plasma/Beam Coagulators, Irreversible Electroporation Ablators
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Treatment, Gynecologic Treatment, Ophthalmologic Treatment, Cardiovascular Disease Treatment, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Biosense
- St. Jude
- Boston
- Angiodynamics
- Atricure
- Smith & Nephew
- Galil Medical
- Conmed
- Olympus
Highlights of The Electrical Ablators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Argon Plasma/Beam Coagulators
- Irreversible Electroporation Ablators
- By Application:
- Cancer Treatment
- Gynecologic Treatment
- Ophthalmologic Treatment
- Cardiovascular Disease Treatment
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Electrical Ablators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Electrical ablators are devices that remove insulation from electrical cables. They are used to make repairs or replacements on electrical wiring, and can also be used to strip insulation from new wire.
Some of the major companies in the electrical ablators market are Medtronic, Biosense, St. Jude, Boston, Angiodynamics, Atricure, Smith & Nephew, Galil Medical, Conmed, Olympus.
The electrical ablators market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Electrical Ablators Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Electrical Ablators Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Electrical Ablators Market - Supply Chain
4.5. Global Electrical Ablators Market Forecast
4.5.1. Electrical Ablators Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Electrical Ablators Market Size (000 Units) and Y-o-Y Growth
4.5.3. Electrical Ablators Market Absolute $ Opportunity
5. Global Electrical Ablators Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Electrical Ablators Market Size and Volume Forecast by Type
5.3.1. Argon Plasma/Beam Coagulators
5.3.2. Irreversible Electroporation Ablators
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Electrical Ablators Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Electrical Ablators Market Size and Volume Forecast by Application
6.3.1. Cancer Treatment
6.3.2. Gynecologic Treatment
6.3.3. Ophthalmologic Treatment
6.3.4. Cardiovascular Disease Treatment
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Electrical Ablators Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Electrical Ablators Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Electrical Ablators Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Electrical Ablators Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Electrical Ablators Demand Share Forecast, 2019-2029
9. North America Electrical Ablators Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Electrical Ablators Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Electrical Ablators Market Size and Volume Forecast by Application
9.4.1. Cancer Treatment
9.4.2. Gynecologic Treatment
9.4.3. Ophthalmologic Treatment
9.4.4. Cardiovascular Disease Treatment
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Electrical Ablators Market Size and Volume Forecast by Type
9.7.1. Argon Plasma/Beam Coagulators
9.7.2. Irreversible Electroporation Ablators
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Electrical Ablators Demand Share Forecast, 2019-2029
10. Latin America Electrical Ablators Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Electrical Ablators Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Electrical Ablators Market Size and Volume Forecast by Application
10.4.1. Cancer Treatment
10.4.2. Gynecologic Treatment
10.4.3. Ophthalmologic Treatment
10.4.4. Cardiovascular Disease Treatment
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Electrical Ablators Market Size and Volume Forecast by Type
10.7.1. Argon Plasma/Beam Coagulators
10.7.2. Irreversible Electroporation Ablators
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Electrical Ablators Demand Share Forecast, 2019-2029
11. Europe Electrical Ablators Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Electrical Ablators Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Electrical Ablators Market Size and Volume Forecast by Application
11.4.1. Cancer Treatment
11.4.2. Gynecologic Treatment
11.4.3. Ophthalmologic Treatment
11.4.4. Cardiovascular Disease Treatment
11.4.5. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Electrical Ablators Market Size and Volume Forecast by Type
11.7.1. Argon Plasma/Beam Coagulators
11.7.2. Irreversible Electroporation Ablators
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Electrical Ablators Demand Share, 2019-2029
12. Asia Pacific Electrical Ablators Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Electrical Ablators Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Electrical Ablators Market Size and Volume Forecast by Application
12.4.1. Cancer Treatment
12.4.2. Gynecologic Treatment
12.4.3. Ophthalmologic Treatment
12.4.4. Cardiovascular Disease Treatment
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Electrical Ablators Market Size and Volume Forecast by Type
12.7.1. Argon Plasma/Beam Coagulators
12.7.2. Irreversible Electroporation Ablators
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Electrical Ablators Demand Share, 2019-2029
13. Middle East & Africa Electrical Ablators Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Electrical Ablators Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Electrical Ablators Market Size and Volume Forecast by Application
13.4.1. Cancer Treatment
13.4.2. Gynecologic Treatment
13.4.3. Ophthalmologic Treatment
13.4.4. Cardiovascular Disease Treatment
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Electrical Ablators Market Size and Volume Forecast by Type
13.7.1. Argon Plasma/Beam Coagulators
13.7.2. Irreversible Electroporation Ablators
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Electrical Ablators Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Electrical Ablators Market: Market Share Analysis
14.2. Electrical Ablators Distributors and Customers
14.3. Electrical Ablators Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biosense
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Angiodynamics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Atricure
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Smith & Nephew
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Galil Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Conmed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Olympus
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
